Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Signal regulatory protein beta 1 (SIRPB1) is a transmembrane glycoprotein receptor belonging to the SIRP family. It is expressed on myeloid cells and, unlike SIRPA, activates signaling through association with the DAP12 adaptor protein, leading to myeloid cell activation. It does not bind CD47. It has been implicated in influencing inflammatory factor expression within the tumor microenvironment and modulating microglial response in Alzheimer's disease models.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Signal regulatory protein beta 1.